Related Experiment Video
Updated: Aug 21, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Should the ascending aorta be replaced more frequently in patients with bicuspid aortic valve disease?
Michael A Borger1, Mark Preston, Joan Ivanov
1Division of Cardiovascular Surgery, Toronto General Hospital, University Health Network, University of Toronto, 200 Elizabeth Street, Toronto, Ontario, Canada M5G 2C4. michael.borger@uhn.on.ca
Insights
For bicuspid aortic valve disease, ascending aorta replacement is recommended at 4.5 cm or greater. This helps prevent serious aortic complications and improve long-term outcomes.
Area of Science:
- Cardiovascular Surgery
- Cardiology
- Genetics
Background:
- Bicuspid aortic valve disease is a common congenital heart defect.
- The optimal management strategy for ascending aorta dilation in these patients remains unclear.
Purpose of the Study:
- To determine the optimal diameter for ascending aorta replacement in patients with bicuspid aortic valve disease.
- To assess the risk of aortic complications based on ascending aorta diameter.
Main Methods:
- Retrospective review of 201 patients with bicuspid aortic valves undergoing aortic valve replacement between 1979 and 1993.
- Exclusion of patients who had concomitant ascending aorta replacement.
- Long-term follow-up to assess survival and aortic complications.
Main Results:
- Fifteen-year freedom from ascending aorta complications was significantly lower in patients with diameters 4.5-4.9 cm (43%) compared to <4.0 cm (86%) and 4.0-4.4 cm (81%).
- Ascending aorta-related complications included aneurysm, dissection, and sudden cardiac death.
- A diameter of 4.5 cm or greater was associated with a substantially increased risk of complications.
Conclusions:
- Concomitant ascending aorta replacement should be strongly considered for patients with bicuspid aortic valve disease when the diameter reaches 4.5 cm or greater.
- Early intervention can mitigate the risk of severe aortic events in this population.
Objective:
The optimal diameter at which replacement of the ascending aorta should be performed in patients with bicuspid aortic valve disease is not known.
Methods:
We reviewed all patients with bicuspid aortic valves undergoing aortic valve replacement at our institution from 1979 through 1993 (n = 201). Patients undergoing concomitant replacement of the ascending aorta were excluded.
Results:
Follow-up was obtained on 98% of patients and was 10.3 +/- 3.8 (mean +/- SD) years. The average patient age was 56 +/- 15 years, and 76% were male. The ascending aorta was normal (<4.0 cm) in 115 (57%) patients, mildly dilated (4.0-4.4 cm) in 64 (32%) patients, and moderately dilated (4.5-4.9 cm) in 22 (11%) patients. All patients with bicuspid aortic valves with marked dilation (>5.0 cm) underwent replacement of the ascending aorta and were therefore excluded. Fifteen-year survival was 67%. During follow-up, 44 patients required reoperation, predominantly for aortic valve prosthesis failure. Twenty-two patients had long-term complications related to the ascending aorta: 18 required an operative procedure to replace the ascending aorta (for aortic aneurysm), 1 had aortic dissection, and 3 experienced sudden cardiac death. Fifteen-year freedom from ascending aorta-related complications was 86%, 81%, and 43% in patients with an aortic diameter of less than 4.0 cm, 4.0 to 4.4 cm, and 4.5 to 4.9 cm, respectively ( P < .001).
Conclusions:
Patients undergoing operations for bicuspid aortic valve disease should be considered for concomitant replacement of the ascending aorta if the diameter is 4.5 cm or greater.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Aortic Regurgitation I: Introduction
Mitral Stenosis III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation IV: Nursing Management
